User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 12 results.
    • Journal article
    86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.
    Jamar, François[UCL] Barone, Raffaella[UCL] Mathieu, Isabelle Walrand, Stephan Labar, Daniel[UCL] Carlier, Pascal[UCL] de Camps, Joëlle Schran, Horst Chen, TianLing Smith, M Charles Bouterfa, Hakim Valkema, Roelf Krenning, Eric P Kvols, Larry K Pauwels, Stanislas[UCL] (2003) European journal of nuclear medicine and molecular imaging — Vol. 30, no. 4, p. 510-8 (2003)
    • Journal article
    Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.
    Valkema, Roelf Pauwels, Stanislas[UCL] Kvols, Larry K Kwekkeboom, Dik J Jamar, François[UCL] de Jong, Marion Barone, Raffaella[UCL] Walrand, Stéphan Kooij, Peter P M Bakker, Willem H Lasher, Janet Krenning, Eric P (2005) Journal of nuclear medicine : official publication, Society of Nuclear Medicine — Vol. 46 Suppl 1, p. 83S-91S (2005)
    • Journal article
    Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
    Walrand, Stephan[UCL] Flux, Glenn D Konijnenberg, Mark W Valkema, Roelf Krenning, Eric P Lhommel, Renaud[UCL] Pauwels, Stanislas[UCL] Jamar, François[UCL] (2011) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 38, no. Suppl. 1, p. S57-568 (2011)
    • Journal article
    Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.
    Krenning, Eric P Valkema, Roelf Kwekkeboom, Dik J de Herder, Wouter W van Eijck, Casper H J de Jong, Marion Pauwels, Stanislas[UCL] Reubi, Jean-Claude (2005) Journal of nuclear medicine : official publication, Society of Nuclear Medicine — Vol. 46 Suppl 1, p. 76S-82S (2005)
    • Journal article
    Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
    Pauwels, Stanislas[UCL] Barone, Raffaella[UCL] Walrand, Stéphan[UCL] Borson-Chazot, Françoise[UCL] Valkema, Roelf Kvols, Larry K Krenning, Eric P Jamar, François[UCL] (2005) The Journal of Nuclear Medicine — Vol. 46 Suppl 1, p. 92S-98S (2005)
    • Journal article
    Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
    Barone, Raffaella[UCL] Pauwels, Stanislas[UCL] De Camps, Joëlle[UCL] Krenning, Eric P Kvols, Larry K Smith, M Charles Bouterfa, Hakim Devuyst, Olivier[UCL] Jamar, François[UCL] (2004) Nephrology, Dialysis, Transplantation — Vol. 19, no. 9, p. 2275-2281 (2004)
    • Journal article
    Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.
    Barone, Raffaella[UCL] Borson-Chazot, Françoise Valkema, Roelf Walrand, Stephan Chauvin, Franck Gogou, Lida Kvols, Larry K Krenning, Eric P Jamar, François[UCL] Pauwels, Stanislas[UCL] (2005) Journal of nuclear medicine : official publication, Society of Nuclear Medicine — Vol. 46 Suppl 1, p. 99S-106S (2005)
    • Journal article
    Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
    De Jong, Marion Valkema, Roelf Jamar, François[UCL] Kvols, Larry K Kwekkeboom, Dik J Breeman, Wout A P Bakker, Willem H Smith, Chuck Pauwels, Stanislas[UCL] Krenning, Eric P (2002) Seminars in Nuclear Medicine — Vol. 32, no. 2, p. 133-140 (2002)
    • Journal article
    Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
    Kwekkeboom, Dik J Mueller-Brand, Jan Paganelli, Giovanni Anthony, Lowell B Pauwels, Stanislas[UCL] Kvols, Larry K O'Dorisio, Thomas M. Valkema, Roelf Bodei, Lisa Chinol, Marco Maecke, Helmut R Krenning, Eric P (2005) Journal of nuclear medicine : official publication, Society of Nuclear Medicine — Vol. 46 Suppl 1, p. 62S-6S (2005)
    • Journal article
    Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Valkema, Roelf Pauwels, Stanislas[UCL] Kvols, Larry K Barone, Raffaella[UCL] Jamar, François[UCL] Bakker, Willem H Kwekkeboom, Dik J Bouterfa, Hakim Krenning, Eric P (2006) Seminars in nuclear medicine — Vol. 36, no. 2, p. 147-56 (2006)
    • Journal article
    Therapy using labelled somatostatin analogues : comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide
    Barone, Raffaella[UCL] Walrand, Stéphan[UCL] Konijnenberg, Mark Valkema, Roelf Kvols, Larry K Krenning, Eric P Pauwels, Stanislas[UCL] Jamar, François[UCL] (2008) Nuclear Medicine Communications — Vol. 29, no. 3, p. 283-290 (2008)
    • Journal article
    Peptide receptor radionuclide therapy.
    Krenning, Eric P Kwekkeboom, Dik J Valkema, Roelf Pauwels, Stanislas[UCL] Kvols, Larry K De Jong, Marion (2004) Annals of the New York Academy of Sciences — Vol. 1014, p. 234-45 (2004)